Resveratrol Reverses Functional Chagas Heart Disease in Mice.

Chronic chagasic cardiomyopathy (CCC) develops years after acute infection by Trypanosoma cruzi and does not improve after trypanocidal therapy, despite reduction of parasite burden. During disease, the heart undergoes oxidative stress, a potential causative factor for arrhythmias and contractile dy...

Full description

Bibliographic Details
Main Authors: Glaucia Vilar-Pereira, Vitor C Carneiro, Hilton Mata-Santos, Amanda R R Vicentino, Isalira P Ramos, Naira L L Giarola, Daniel F Feijó, José R Meyer-Fernandes, Heitor A Paula-Neto, Emiliano Medei, Marcelo T Bozza, Joseli Lannes-Vieira, Claudia N Paiva
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-10-01
Series:PLoS Pathogens
Online Access:https://doi.org/10.1371/journal.ppat.1005947
_version_ 1819133127237304320
author Glaucia Vilar-Pereira
Vitor C Carneiro
Hilton Mata-Santos
Amanda R R Vicentino
Isalira P Ramos
Naira L L Giarola
Daniel F Feijó
José R Meyer-Fernandes
Heitor A Paula-Neto
Emiliano Medei
Marcelo T Bozza
Joseli Lannes-Vieira
Claudia N Paiva
author_facet Glaucia Vilar-Pereira
Vitor C Carneiro
Hilton Mata-Santos
Amanda R R Vicentino
Isalira P Ramos
Naira L L Giarola
Daniel F Feijó
José R Meyer-Fernandes
Heitor A Paula-Neto
Emiliano Medei
Marcelo T Bozza
Joseli Lannes-Vieira
Claudia N Paiva
author_sort Glaucia Vilar-Pereira
collection DOAJ
description Chronic chagasic cardiomyopathy (CCC) develops years after acute infection by Trypanosoma cruzi and does not improve after trypanocidal therapy, despite reduction of parasite burden. During disease, the heart undergoes oxidative stress, a potential causative factor for arrhythmias and contractile dysfunction. Here we tested whether antioxidants/ cardioprotective drugs could improve cardiac function in established Chagas heart disease. We chose a model that resembles B1-B2 stage of human CCC, treated mice with resveratrol and performed electrocardiography and echocardiography studies. Resveratrol reduced the prolonged PR and QTc intervals, increased heart rates and reversed sinus arrhythmia, atrial and atrioventricular conduction disorders; restored a normal left ventricular ejection fraction, improved stroke volume and cardiac output. Resveratrol activated the AMPK-pathway and reduced both ROS production and heart parasite burden, without interfering with vascularization or myocarditis intensity. Resveratrol was even capable of improving heart function of infected mice when treatment was started late after infection, while trypanocidal drug benznidazole failed. We attempted to mimic resveratrol's actions using metformin (AMPK-activator) or tempol (SOD-mimetic). Metformin and tempol mimicked the beneficial effects of resveratrol on heart function and decreased lipid peroxidation, but did not alter parasite burden. These results indicate that AMPK activation and ROS neutralization are key strategies to induce tolerance to Chagas heart disease. Despite all tissue damage observed in established Chagas heart disease, we found that a physiological dysfunction can still be reversed by treatment with resveratrol, metformin and tempol, resulting in improved heart function and representing a starting point to develop innovative therapies in CCC.
first_indexed 2024-12-22T09:42:21Z
format Article
id doaj.art-620113a7b3334c11a095afab687e175b
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-12-22T09:42:21Z
publishDate 2016-10-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-620113a7b3334c11a095afab687e175b2022-12-21T18:30:38ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742016-10-011210e100594710.1371/journal.ppat.1005947Resveratrol Reverses Functional Chagas Heart Disease in Mice.Glaucia Vilar-PereiraVitor C CarneiroHilton Mata-SantosAmanda R R VicentinoIsalira P RamosNaira L L GiarolaDaniel F FeijóJosé R Meyer-FernandesHeitor A Paula-NetoEmiliano MedeiMarcelo T BozzaJoseli Lannes-VieiraClaudia N PaivaChronic chagasic cardiomyopathy (CCC) develops years after acute infection by Trypanosoma cruzi and does not improve after trypanocidal therapy, despite reduction of parasite burden. During disease, the heart undergoes oxidative stress, a potential causative factor for arrhythmias and contractile dysfunction. Here we tested whether antioxidants/ cardioprotective drugs could improve cardiac function in established Chagas heart disease. We chose a model that resembles B1-B2 stage of human CCC, treated mice with resveratrol and performed electrocardiography and echocardiography studies. Resveratrol reduced the prolonged PR and QTc intervals, increased heart rates and reversed sinus arrhythmia, atrial and atrioventricular conduction disorders; restored a normal left ventricular ejection fraction, improved stroke volume and cardiac output. Resveratrol activated the AMPK-pathway and reduced both ROS production and heart parasite burden, without interfering with vascularization or myocarditis intensity. Resveratrol was even capable of improving heart function of infected mice when treatment was started late after infection, while trypanocidal drug benznidazole failed. We attempted to mimic resveratrol's actions using metformin (AMPK-activator) or tempol (SOD-mimetic). Metformin and tempol mimicked the beneficial effects of resveratrol on heart function and decreased lipid peroxidation, but did not alter parasite burden. These results indicate that AMPK activation and ROS neutralization are key strategies to induce tolerance to Chagas heart disease. Despite all tissue damage observed in established Chagas heart disease, we found that a physiological dysfunction can still be reversed by treatment with resveratrol, metformin and tempol, resulting in improved heart function and representing a starting point to develop innovative therapies in CCC.https://doi.org/10.1371/journal.ppat.1005947
spellingShingle Glaucia Vilar-Pereira
Vitor C Carneiro
Hilton Mata-Santos
Amanda R R Vicentino
Isalira P Ramos
Naira L L Giarola
Daniel F Feijó
José R Meyer-Fernandes
Heitor A Paula-Neto
Emiliano Medei
Marcelo T Bozza
Joseli Lannes-Vieira
Claudia N Paiva
Resveratrol Reverses Functional Chagas Heart Disease in Mice.
PLoS Pathogens
title Resveratrol Reverses Functional Chagas Heart Disease in Mice.
title_full Resveratrol Reverses Functional Chagas Heart Disease in Mice.
title_fullStr Resveratrol Reverses Functional Chagas Heart Disease in Mice.
title_full_unstemmed Resveratrol Reverses Functional Chagas Heart Disease in Mice.
title_short Resveratrol Reverses Functional Chagas Heart Disease in Mice.
title_sort resveratrol reverses functional chagas heart disease in mice
url https://doi.org/10.1371/journal.ppat.1005947
work_keys_str_mv AT glauciavilarpereira resveratrolreversesfunctionalchagasheartdiseaseinmice
AT vitorccarneiro resveratrolreversesfunctionalchagasheartdiseaseinmice
AT hiltonmatasantos resveratrolreversesfunctionalchagasheartdiseaseinmice
AT amandarrvicentino resveratrolreversesfunctionalchagasheartdiseaseinmice
AT isalirapramos resveratrolreversesfunctionalchagasheartdiseaseinmice
AT nairallgiarola resveratrolreversesfunctionalchagasheartdiseaseinmice
AT danielffeijo resveratrolreversesfunctionalchagasheartdiseaseinmice
AT josermeyerfernandes resveratrolreversesfunctionalchagasheartdiseaseinmice
AT heitorapaulaneto resveratrolreversesfunctionalchagasheartdiseaseinmice
AT emilianomedei resveratrolreversesfunctionalchagasheartdiseaseinmice
AT marcelotbozza resveratrolreversesfunctionalchagasheartdiseaseinmice
AT joselilannesvieira resveratrolreversesfunctionalchagasheartdiseaseinmice
AT claudianpaiva resveratrolreversesfunctionalchagasheartdiseaseinmice